Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry-Reference-Cited by-同舟云学术

Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry

Published:2013-02-06 Issue:5 Volume:102 Page:371-381
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Akin Ibrahim,Hochadel Matthias,Abdel-Wahab Mohamed,Senges Jochen,Richardt Gert,Schneider Steffen,Tebbe Ulrich,Kuck Karl-Heinz,Nienaber Christoph A.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-013-0546-5.pdf

Reference43 articles.

1. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB (2007) Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stent. N Engl J Med 356:998–1008

2. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabate M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370:937–948

3. Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH, DES.DE Study Group (2009) Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare-metal stents (from the first phase of the prospective multicenter German DES.DE Registry). Am J Cardiol 104:1362–1369

4. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersch B, Pocock SJ, Dangas G, Wong SC, Fahy M, Parise H, Mehran R, on behalf of the HORIZONS-AMI Trial Investigators (2009) Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZON-AMI): final 3-year results from a multicentre, randomized controlled trial. Lancet 374:1149–1159

5. Leon MB, Allocco DJ, Dawkins KD, Baim DS (2009) Late clinical events after drug-eluting stents. The interplay between stent-related and natural history-driven events. J Am Coll Cardiol Intv 2:504–512

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review and meta-analysis of 6 randomized controlled trials;BMC Cardiovascular Disorders;2017-03-16

2. Radiation exposure during the implantation of bioabsorbable vascular scaffolds versus drug-eluting stents in non-complex coronary lesions: a matched-cohort study;Minerva Cardiology and Angiology;2016-11

3. Endothelial progenitor cell capture stents versus drug-eluting stents for angina or acute coronary syndrome;Cochrane Database of Systematic Reviews;2016-08-22

4. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials;Clinical Research in Cardiology;2015-12-22

5. Cardiac surgery 2014 reviewed;Clinical Research in Cardiology;2015-09-24